Date: 2 Dec, 2024
NLB d.d., Ljubljana
Disclosure regarding the minimum requirement for own funds and eligible liabilities pursuant to article 62(5) of the ZRPPB-1
In accordance with the requirements of paragraph 5 of Article 62 of Zakon o reševanju in prisilnem prenehanju bank (ZRPPB-1), NLB d.d. is hereby publishing the amounts and composition of the own funds and eligible liabilities and minimum requirement for own funds and eligible liabilities (MREL) applicable to the NLB Resolution Group.
Data as of 2 December 2024 | in EUR | Maturity | Order of priority under normal insolvency proceedings |
| | | |
1. Equity | | | |
|
|
|
|
1.1 Common Equity Tier 1: |
|
| |
· NLB Resolution Group common equity tier 1 items | 1,908,541,000[1] | Without maturity | Junior to all other liabilities. |
1.2 Additional Tier 1 Instruments: |
|
|
|
· Subordinated notes (ISIN SI0022104275) | 82,000,000 | Notes are perpetual and have no scheduled maturity date. The Issuer has the possibility for early redemption of the notes on any business day from 23 September 2027 to 23 March 2028 and on 23 September each year commencing on 23 September 2028
| Senior to the Common Equity Tier 1 Instruments (point 1.1.) and junior to all other liabilities. |
1.3 Tier 2 Instruments: |
|
|
|
| | | |
· Subordinated notes (ISIN XS2113139195) | 10,500,000 | 5 February 2030; NLB d.d. has the option to redeem the notes on 5 February 2025 | Senior to the Common Equity Tier 1 Instruments (point 1.1) and any Additional Tier 1 Instrument (point 1.2), junior to all other liabilities. |
· Subordinated notes (ISIN XS2413677464) | 225,000,000 | 28 November 2032; NLB d.d. has the option to redeem the notes on 28 November 2027 | |
· Subordinated notes (ISIN XS2750306511) | 300,000,000 | 24 January 2034; NLB d.d. has the option to redeem the notes on 24 January 2029 | |
| |||
2. Eligible liabilities | |||
2.1 Unsecured and unsubordinated claims arising from debt instruments (referred to in second paragraph, point 8 of Article 230): | | ||
· Notes (ISIN XS2641055012) | 500,000,000 | 27 June 2027; NLB d.d. has the option to redeem the notes on 27 June 2026 | Senior to the Tier 2 Instruments (point 1.3) and junior to all liabilities referred to in second paragraph of Article 230 of ZRPPB-1, points 1 to 7. |
· Notes (ISIN XS2825558328) | 500,000,000 | 29 May 2030; NLB d.d. has the option to redeem the notes on 29 May 2029 | |
| | | |
2.2 MREL eligible deposits (referred to in second paragraph, point 6 of Article 230): | Senior to the unsecured and unsubordinated claims arising from debt instruments (point 2.1) and other unsecured claims (referred to in second paragraph of Article 230 of ZRPPB-1, point 7), and junior to all liabilities referred to in second paragraph of Article 230 of ZRPPB-1, points 1 to 5.
| ||
· MREL eligible deposit | 5,000,000 | 30 December 2025 | |
· MREL eligible deposit | 5,000,000 | 5 January 2026 | |
· MREL eligible deposit | 5,000,000 | 22 December 2026 | |
· MREL eligible deposit | 5,000,000 | 4 January 2027 | |
|
| |
|
2.3 MREL eligible deposits (referred to in second paragraph, point 5 of Article 230): | |||
MREL eligible deposit | 20,000,000 | 3 August 2026 | Senior to the MREL eligible deposits (referred to in second paragraph, point 6) (point 2.2) and junior to all liabilities referred to in second paragraph of Article 230 of ZRPPB-1, points 1 to 4. |
MREL eligible deposit | 20,000,000 | 25 August 2026 | |
|
| |
|
Total amount of equity and eligible qualified liabilities items | 3,586,041,000 | |
|
The applicable minimum requirement of own funds and eligible liabilities'
| As of 1 January 2024, NLB d.d. shall comply with MREL requirement on a consolidated basis at resolution group level (consisting of NLB d.d. and other members of the NLB Group excluding banks) which amounts to 30.66% of Total Risk Exposure Amount (TREA), increased by the applicable combined buffer requirement; and 10.69% of the Leverage Ratio Exposure (LRE).
|
Investor Relations
NLB d.d. Ljubljana
[1] Data as per 31 October 2024.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.